Evidence map›Paper›PMID 33136280›Full record

ArticleUpdates in surgery2021

The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study.

Matteo Serenari, Chiara Bonatti, Lucia Zanoni, Giuliano Peta, Elena Tabacchi, Alessandro Cucchetti, Matteo Ravaioli, Cinzia Pettinato, Alberto Bagni, Antonio Siniscalchi and 4 more

Abstract read
In one paragraph

Article in Updates in surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Matteo SerenariGeneral Surgery and Transplantation Unit, Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy. matteo.serenari@gmail.com.ORCID http://orcid.org/0000-0003-1471-8585
Chiara BonattiDepartment of Medical and Surgical Sciences, DIMEC, Alma Mater Studiorum, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
Lucia ZanoniNuclear Medicine Unit, Azienda Ospedaliera-Universitaria di Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Giuliano PetaRadiology Unit, Department of Diagnostic and Preventive Medicine, Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Elena TabacchiNuclear Medicine Unit, Azienda Ospedaliera-Universitaria di Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Alessandro CucchettiDepartment of Medical and Surgical Sciences, DIMEC, Alma Mater Studiorum, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
Matteo RavaioliGeneral Surgery and Transplantation Unit, Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
Cinzia PettinatoMedical Physics Unit, Radiology Unit, S. Orsola-Malpighi Hospital, Bologna, Italy.
Alberto BagniPathology Unit, Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Antonio SiniscalchiDivision of Anesthesiology, Azienda Ospedaliera-Universitaria di Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Antonietta D'ErricoPathology Unit, Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Rita GolfieriRadiology Unit, Department of Diagnostic and Preventive Medicine, Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Stefano FantiNuclear Medicine Unit, Azienda Ospedaliera-Universitaria di Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Matteo CesconGeneral Surgery and Transplantation Unit, Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatobiliary scintigraphy (HBS) has been demonstrated to predict post-hepatectomy liver failure (PHLF). However, existing cutoff values for future liver remnant function (FLR-F) were previously set according to the "50-50 criteria" PHLF definition. Methods of calculation and fields of application in liver surgery have changed in the meantime. The aim of this study was to demonstrate the role of HBS combined with single photon emission computed tomography (SPECT/CT) in predicting severity of PHLF, according to the International Study Group of Liver Surgery (ISGLS). All patients submitted to major hepatectomy with preoperative HBS-SPECT/CT between November 2016 and December 2019, were analyzed. Patients were resected according to hepatic volumetry. Receiver operating characteristic (ROC) curve analysis was performed to identify cutoffs of FLR function for predicting PHLF according to ISGLS definition and grading. Of the 38 patients enrolled, 26 were submitted to one-stage hepatectomy (living liver donors = 4) and 12 to two-stage procedures (portal vein embolization = 4, ALPPS = 8). Overall, 18 patients developed PHLF according to ISGLS criteria: 12 of grade A (no change in the patient's clinical management) and 6 of grade B (change in clinical management). ROC analysis established increasingly higher cutoffs of FLR-F for predicting PHLF according to the "50-50 criteria", ISGLS grade B and ISGLS grade A/B, respectively. HBS with SPECT/CT may help to assess severity of PHLF following major hepatectomy. Prospective multicenter trials are needed to confirm the effective role of HBS-SPECT/CT in liver surgery.

Indexed as

Radionuclide ImagingSingle Photon Emission Computed Tomography Computed TomographyAdultAgedAged, 80 and overFemaleHepatectomyHumansLiverLiver FailureLiver NeoplasmsMaleMiddle AgedPilot ProjectsPostoperative ComplicationsPredictive Value of TestsHepatectomyHepatobiliary scintigraphyLiver failureMebrofeninSPECT

Identifiers

PMID33136280
PMCPMC7889556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.